$1.450
-0.020 (-1.36%)Zum Schluss
ISPR-News
ISPR-Events
Stocks Fall as Fed Raises Rates, S&P 500 Drops 0.45%
Stocks fell toward their lowest levels since July as the Federal Reserve signaled the possibility of further policy tightening after raising rates for the first time since 2023. Equities erased gains, with the S&P 500 dropping 0.45% and the Dow Jones Industrial Average losing over 1% after the Federal Open Market Committee voted unanimously to increase the benchmark rate to a range of 3.75% to 4%. The Fed's "dot plot" that signals members' view of the outlook for the path of monetary policy suggests one more hike may be coming this year.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:OpenAI has held early conversations with investors about raising another private funding round at a $1.2T valuation before its planned IPO,SK Hynixis in talks with Intelabout a deal to manufacture memory chips in the U.S. for the first time,Appleis developing an enterprise AI server using its own chips and potentially Nvidianetworking equipment,Starbucksis exploring a sale of a majority stake in its Japan business,Trucker J.B. Huntissued abeing hurt by higher costs2. WALL STREET CALLS:Alvotechfrom Underweight at BarclaysStellantisfrom Buy at BerenbergSimilarwebfrom Hold at NeedhamExpediafrom Equal Weight at Morgan StanleyCiti opened anon Metaahead of the company's Connect conference on September 233. AROUND THE WEB:Nvidia, MetaCEOs argue against AI slowdown, FT reportsMucinex and Lysol maker Reckitt Benckiserplans to invest about $400M more over the next four years in the U.S. to speed up product innovation and demand response, WSJ reportsChicago District Judge John Tharp dissolved a previous order that required multiple listings service provider Midwest Real Estate Data to temporarily maintain Zillow'saccess to listings, Reuters saysMetaplans to release a camera-free pair of smart glasses this fall, The Information reportsGoogleis giving all its engineers access to Anthropic's Claude Opus 5 via Antigravity, and says "Gemini remains our primary and foundational model for internal development," Business Insider says4. MOVERS:GE Vernovaafter the power equipment company said it expects to grow to a $200B backlog early next yearTormafter announcing Hafniahas agreed to acquire 4.5M of its sharesBloom Energyafter releasing "The New Rules of AI Power" reportBraskemafter UBS downgraded the stock to SellBorr Drillingafter providing an operational update5. EARNINGS/GUIDANCE:Cienaannouncedout to fiscal year 2029Huntington Bancsharesfor FY27Mercury Systemsfor FY27Trip.comreported, with CEO Jane Sun commenting the company delivered a "resilient performance" in Q2Ispire Technologyreported, with EPS and revenue higher year-over-yearINDEXES:The Dow fell 631.21, or 1.21%, to 51,461.90, the Nasdaq lost 3.15, or 0.01%, to 25,978.42, and the S&P 500 declined 33.92, or 0.45%, to 7,551.81.
Stocks Inch Higher as Markets Assess Rate Hike Impact
Stocks inched higher on Wednesday morning, pausing the week's pullback as markets assessed how the economy may fare against higher interest rates. The Federal Reserve is expected to raise interest rates by 25 basis points later today, although the summary of economic projections - or "dot plot" - is likely to show a fragmented FOMC as uncertain outlooks spark disagreements on policy and forward guidance. Hawkish concerns were further stoked with the release of strong retail sales and soaring import inflation figures this morning.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:OpenAI has held early conversations with investors aboutround at a $1.2T valuation before its planned IPO, Financial Times saysSK Hynixis in talks with Intelabout a deal toin the U.S. for the first time, Reuters reportsAppleis developing anusing its own chips and potentially Nvidianetworking equipment, The Information saysStarbucksisof a majority stake in its Japan business, Reuters reportsTrucker J.B. Hunton Q3 earnings being hurt by higher costs2. WALL STREET CALLS:Alvotechto Overweight from Underweight at BarclaysStellantisto Hold from Buy at BerenbergSimilarwebto Buy from Hold at NeedhamExpediawith Underweight from Equal Weight at Morgan StanleyCiti opened an "upside" on Metaahead of the company's Connect conference on September 233. AROUND THE WEB:Nvidia, MetaCEOs argue against AI slowdown, FT reportsMucinex and Lysol maker Reckitt Benckiserplans to invest about $400M more over the next four years in the U.S. to speed up product innovation and demand response, WSJ reportsChicago District Judge John Tharp dissolved a previous order that required multiple listings service provider Midwest Real Estate Data to temporarily maintain Zillow'saccess to listings, Bloomberg saysMetaplans to release a camera-free pair of smart glasses this fall, The Information reportsGoogleis giving all its engineers access to Anthropic's Claude Opus 5 via Antigravity, and says "Gemini remains our primary and foundational model for internal development," Business Insider says4. MOVERS:Beta Bionicsincreases after announcing aTormgains in New York after announcing Hafniahas4.5M of its sharesBloom Energyhigher after"The New Rules of AI Power" reportBraskemfalls after UBSthe stock to SellBorr Drillinglower afteron the Odin5. EARNINGS/GUIDANCE:LuxExperiencewith EPS lower year-over-yearHuntington Bancsharesfor FY27Mercury Systemsfor FY27Trip.com, with CEO Jane Sun commenting the company delivered a "resilient performance" in Q2Ispire Technology, with EPS and revenue higher year-over-yearINDEXES:Near midday, the Dow was up 37.94, or 0.07%, to 52,131.05, the Nasdaq was up 210.74, or 0.81%, to 26,192.31, and the S&P 500 was up 33.90, or 0.45%, to 7,619.63.
Ispire Reports Q4 Revenue of $26.7M, Up 33% Year-over-Year
Reports revenue $26.7M vs. $20.1M last year. Steven Przybyla, President of Ispire, commented, "We believe fourth quarter results mark an important inflection point for the company and the turnaround we began more than a year ago. Fourth quarter revenue increased 33% year-over-year and 43% sequentially to $26.7 million, while operating cash flow also increased sequentially. In our view, these results demonstrate that the restructuring and investments we have made are beginning to translate into improved operating performance and position us for a fundamentally improved fiscal 2027. Our Malaysia manufacturing facility is now fully operational, our Vapor ODM platform is entering the market, and we continue to advance IKE Tech's proprietary age-gating technology toward commercialization. We have also begun to expand beyond vaping through our joint venture with Jincheng Pharma, giving us a platform to enter the rapidly growing nicotine pouch market. These initiatives span different stages of development and create a diversified set of possible growth drivers. In the near term, we believe our Malaysia manufacturing and ODM platforms are positioned to expand our addressable customer base, strengthen our competitive position and generate new revenue opportunities. Over the longer term, IKE Tech's age-gating technology is showing the potential to address significant unmet needs in not just the U.S. market, but globally, while our G-Mesh continues to generate interest from leading global tobacco companies and major international brands. We believe fiscal 2027 will be a transformational year of fundamental growth and change for Ispire. We expect it will be the first full year of vapor and nicotine pouch production at our company-owned factories in Malaysia, a year of major commercial developments and contracts within our IKE Tech joint venture and a year of continued investment in cutting-edge technologies that we believe can be highly accretive to the balance sheet and long-term value of the business.
Company Adjusts Cash Flow Positive Expectation to Second Half of FY2027
The company said, "The Company previously expected to achieve cash-flow-positive performance in the second half of calendar year 2026. While operating cash flow has improved substantially year over year, the Company has made investments related to its Malaysia manufacturing facility during the first quarter of fiscal year 2027, which makes the timing of achieving cash-flow positive less certain. Management remains focused on reaching positive cash flow as the benefits of the Company's new manufacturing and commercial programs begin to scale."
Ispire Forms Joint Venture with Shandong Jincheng Pharma
Ispire Technology has entered into a joint venture with Shandong Jincheng Pharma, a global pharmaceutical company, to manufacture and commercialize nicotine pouch products. The joint venture marks Ispire's entry into the oral nicotine category. Jincheng Pharma will contribute manufacturing equipment, technical expertise, and nicotine pouch materials. Jincheng Pharma is a diversified pharmaceutical company with approximately 3,800 employees and more than 30 affiliated companies worldwide. The company is engaged in the research, development, production, and commercialization of pharmaceutical intermediates, active pharmaceutical ingredients, finished pharmaceutical products, and health-related products. The company expects initial production to be supported by existing commercial relationships and intends to pursue additional business development opportunities within the oral nicotine segment as part of its broader international nicotine platform strategy.
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.








